A detailed history of Mountain Pacific Investment Advisers Inc transactions in Danaher Corp stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 210,556 shares of DHR stock, worth $48.6 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares
210,556
Previous 208,914 0.79%
Holding current value
$48.6 Million
Previous $52.2 Million 12.14%
% of portfolio
4.12%
Previous 3.95%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$239.25 - $280.76 $392,848 - $461,007
1,642 Added 0.79%
210,556 $58.5 Million
Q2 2024

Jul 10, 2024

SELL
$235.51 - $267.98 $12.6 Million - $14.3 Million
-53,533 Reduced 20.4%
208,914 $52.2 Million
Q1 2024

Apr 11, 2024

SELL
$224.58 - $256.19 $260,512 - $297,180
-1,160 Reduced 0.44%
262,447 $65.5 Million
Q4 2023

Feb 02, 2024

BUY
$185.1 - $233.13 $101,619 - $127,988
549 Added 0.21%
263,607 $61 Million
Q3 2023

Oct 20, 2023

SELL
$233.08 - $265.59 $283,658 - $323,223
-1,217 Reduced 0.46%
263,058 $65.3 Million
Q2 2023

Jul 26, 2023

SELL
$224.99 - $256.14 $353,909 - $402,908
-1,573 Reduced 0.59%
264,275 $63.4 Million
Q1 2023

May 23, 2023

SELL
$239.75 - $277.0 $843,200 - $974,209
-3,517 Reduced 1.31%
265,848 $67 Million
Q4 2022

Jan 20, 2023

SELL
$241.42 - $282.29 $12,553 - $14,679
-52 Reduced 0.02%
269,365 $0
Q3 2022

Oct 13, 2022

SELL
$247.06 - $1507.4 $2.28 Million - $13.9 Million
-9,243 Reduced 3.32%
269,417 $69.6 Million
Q2 2022

Jul 21, 2022

SELL
$237.11 - $299.66 $510,023 - $644,568
-2,151 Reduced 0.77%
278,660 $70.6 Million
Q1 2022

Apr 19, 2022

SELL
$257.27 - $315.76 $847,190 - $1.04 Million
-3,293 Reduced 1.16%
280,811 $82.4 Million
Q4 2021

Jan 19, 2022

SELL
$292.08 - $329.01 $1.77 Million - $1.99 Million
-6,049 Reduced 2.08%
284,104 $93.5 Million
Q3 2021

Oct 25, 2021

SELL
$272.21 - $332.43 $672,358 - $821,102
-2,470 Reduced 0.84%
290,153 $88.3 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $2.49 Million - $3 Million
-11,047 Reduced 3.64%
292,623 $78.5 Million
Q1 2021

Apr 14, 2021

SELL
$212.38 - $245.9 $961,656 - $1.11 Million
-4,528 Reduced 1.47%
303,670 $68.4 Million
Q4 2020

Jan 21, 2021

SELL
$212.5 - $245.46 $2.84 Million - $3.29 Million
-13,386 Reduced 4.16%
308,198 $68.5 Million
Q3 2020

Oct 13, 2020

SELL
$177.16 - $215.33 $3.27 Million - $3.98 Million
-18,484 Reduced 5.44%
321,584 $69.2 Million
Q2 2020

Jul 09, 2020

SELL
$128.7 - $176.83 $2.17 Million - $2.98 Million
-16,875 Reduced 4.73%
340,068 $60.1 Million
Q1 2020

Apr 08, 2020

SELL
$121.39 - $169.05 $298,619 - $415,863
-2,460 Reduced 0.68%
356,943 $49.4 Million
Q4 2019

Jan 21, 2020

SELL
$133.47 - $153.48 $136,139 - $156,549
-1,020 Reduced 0.28%
359,403 $55.2 Million
Q3 2019

Oct 15, 2019

SELL
$135.4 - $146.47 $390,358 - $422,273
-2,883 Reduced 0.79%
360,423 $52.1 Million
Q2 2019

Jul 23, 2019

SELL
$124.88 - $143.73 $152,353 - $175,350
-1,220 Reduced 0.33%
363,306 $51.9 Million
Q1 2019

May 07, 2019

SELL
$97.62 - $132.29 $163,025 - $220,924
-1,670 Reduced 0.46%
364,526 $48.1 Million
Q4 2018

Jan 25, 2019

BUY
$94.85 - $109.54 $118,657 - $137,034
1,251 Added 0.34%
366,196 $37.8 Million
Q3 2018

Nov 14, 2018

SELL
$98.13 - $108.9 $466,706 - $517,928
-4,756 Reduced 1.29%
364,945 $39.7 Million
Q2 2018

Jul 25, 2018

BUY
$96.1 - $103.24 $33,250 - $35,721
346 Added 0.09%
369,701 $36.5 Million
Q1 2018

Apr 30, 2018

SELL
$92.16 - $103.8 $205,793 - $231,785
-2,233 Reduced 0.6%
369,355 $36.2 Million
Q4 2017

Jan 23, 2018

SELL
$85.26 - $94.62 $485,726 - $539,050
-5,697 Reduced 1.51%
371,588 $34.5 Million
Q3 2017

Oct 20, 2017

BUY
$79.29 - $88.45 $29.9 Million - $33.4 Million
377,285
377,285 $32.4 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Mountain Pacific Investment Advisers Inc Portfolio

Follow Mountain Pacific Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.